A study exploring healthcare professionals' experiences using a ready-to-use botulinum toxin for cosmetic treatments in UK aesthetic clinics
This study is exploring how healthcare professionals in UK aesthetic clinics experience using a new, ready-to-use product called RelabotulinumtoxinA. This treatment is given by injection to reduce the appearance of facial lines, like frown lines and crow’s feet. Unlike older versions, this new one doesn’t need mixing before use, which might save time and reduce waste. The study wants to understand how clinics find using this new product in their everyday work, including how easy it is, its impact on their daily routines, and any financial aspects. Patients themselves aren't directly involved in the study, but the healthcare professionals will observe how their patients respond to the treatment.
At a glance
What is this study about?
This study is all about a new type of medicine used for cosmetic treatments, specifically for facial lines such as those between the eyebrows (frown lines) and around the eyes (crow's feet). You might know these treatments by their common name, 'Botox', which is a type of botulinum toxin. Doctors, dentists, and nurses often use these treatments in aesthetic clinics across the UK.
The exciting part of this study is that it focuses on a newer version of this medicine, called RelabotulinumtoxinA. What makes it different is that it comes already prepared and ready to use, unlike older versions which needed to be mixed just before injection. The people running this study think this ready-to-use option could save clinics time, reduce waste, and help ensure consistent results for patients.
The main goal of the 'PURE-QUEST' study is to understand what it's like for healthcare professionals in aesthetic clinics to use this new ready-to-use product. They want to know if it's easier to use, how it affects their daily work, and if it makes their clinics run more smoothly. They'll also be looking at how happy patients seem with the results (as observed by the healthcare professionals themselves). This information will help guide decisions about using this new product in the future.
Key takeaways
- This study evaluates a new, ready-to-use facial line treatment for cosmetic clinics.
- It focuses on healthcare professionals' experiences, not patients.
- The new product aims to be more convenient and consistent.
- Clinics will use the product as part of their routine care.
- Healthcare professionals will share their feedback through questionnaires.
- The study helps understand the day-to-day use and benefits of the new treatment.
Who may be eligible?
This study is for healthcare professionals working in private aesthetic clinics within the UK. This includes doctors, dentists, or nurses who are qualified to give these types of treatments.
To take part, these professionals must have at least three years of experience treating patients with botulinum toxin for cosmetic reasons. The clinics also need to have the right equipment, including safe storage for the medicine and a proper treatment room. They should also be prepared to use the new treatment on at least 10 patients as part of their usual care.
Patients receiving treatment at these clinics are not directly part of the study, and no personal information about them will be collected. So, if you're a patient, you can't join this study yourself.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you a doctor, dentist, or nurse who gives cosmetic treatments?
- Do you work in a UK aesthetic clinic?
- Do you have at least 3 years of experience giving botulinum toxin treatments?
- Is your clinic able to safely store and use these types of medicines?
- Are you willing to complete three short surveys over six months?
What does participation involve?
This study is for healthcare professionals, not patients. If a clinic joins the study, they will receive 10 vials of the new RelabotulinumtoxinA product to use with their patients as they normally would. The healthcare professionals will then complete three online questionnaires:
* One questionnaire before they start using the new product. * Another questionnaire one month after they start using it. * And a final questionnaire six months after they start using it.
These questionnaires will ask about their experience using the product, how easy it is, how it affects their clinic's daily work, and how satisfied they believe their patients are. Patients receiving the treatment will have their usual appointments and will not need any extra visits or procedures for the study. All information collected will be kept private and anonymous.
Potential risks and benefits
Locations (1)
- Not provided at time of registrationCity only-, England
Common questions
What kind of treatment are they studying?
They are studying a new, ready-to-use injection treatment called RelabotulinumtoxinA, which is used to smooth out facial lines like frown lines and crow's feet.
Who is this study for?
This study is for experienced doctors, dentists, and nurses who give cosmetic treatments in aesthetic clinics across the UK. It is not for patients.
Will patients have to do anything extra for this study?
No, patients receiving treatment will have their normal appointments and won't need any extra tests or visits for the study.
What will healthcare professionals do in the study?
They will use the new product in their clinic as usual and fill out three online questionnaires about their experience over six months.
When does the study start and finish?
The study is planned to run from September 2024 until August 2026.
How to find out more
Lukasz Adamek
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.